MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
3.100
+0.070
+2.31%
Closed 19:37 02/11 EST
OPEN
3.030
PREV CLOSE
3.030
HIGH
3.150
LOW
3.020
VOLUME
83.85K
TURNOVER
0
52 WEEK HIGH
4.668
52 WEEK LOW
2.070
MARKET CAP
99.81M
P/E (TTM)
-7.8760
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANIX last week (0203-0207)?
Weekly Report · 2d ago
Weekly Report: what happened at ANIX last week (0127-0131)?
Weekly Report · 02/03 10:11
Director Shows Confidence in Anixa Biosciences with New Stock Purchase
TipRanks · 01/29 21:01
Weekly Report: what happened at ANIX last week (0120-0124)?
Weekly Report · 01/27 10:12
Anixa Biosciences Is Maintained at Buy by D. Boral Capital
Dow Jones · 01/22 13:33
ANIXA BIOSCIENCES INC: WITH $20 MLN IN CASH AND INVESTMENTS, WE HAVE A CASH RUNWAY OF OVER 2.5 YEARS
Reuters · 01/21 13:30
Weekly Report: what happened at ANIX last week (0113-0117)?
Weekly Report · 01/20 10:08
Biotech Alert: Searches spiking for these stocks today
TipRanks · 01/17 16:35
More
About ANIX
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. The Company's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. The Company is engaged in the development of vaccines for the treatment or prevention of triple negative breast cancer and other breast cancers which express the α-lactalbumin protein. Its vaccine technologies are focused on immunizing against retired proteins that have been found to be expressed in certain forms of cancer.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.